Retour
Fourchette du Jour
0,86 €
0,86 €
Fourchette 52 Semaines
0,52 €
1,00 €
Volume
852
Moyenne 50J / 200J
0,80 €
/
0,80 €
Clôture Précédente
0,86 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (627 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | -13,8 | 0,4 |
| P/B | 3,5 | 2,9 |
| ROE % | -22,2 | 3,7 |
| Net Margin % | -22,4 | 3,9 |
| Rev Growth 5Y % | -20,9 | 10,0 |
| D/E | 1,0 | 0,2 |
Objectif de Cours des Analystes
Aucune couverture d'analyste disponible
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2028 |
0,00 €
0,00 € – 0,00 €
|
590 M | 0 |
| FY2027 |
1,20 €
0,93 € – 1,39 €
|
2,6 B | 1 |
| FY2026 |
-0,16 €
-0,18 € – -0,12 €
|
450 M | 1 |
Points Clés
Revenue declined -20,87% annually over 5 years
Negative free cash flow of -343,18M
PEG of 0,31 suggests growth is underpriced
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 8,66%
Capital efficient — spends only 0,00% of revenue on capex
Croissance
Revenue Growth (5Y)
-20,87%
Revenue (1Y)-12,21%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Qualité
Return on Equity
-22,23%
ROIC-9,55%
Net Margin-22,40%
Op. Margin-22,52%
Sécurité
Debt / Equity
0,98
Current Ratio1,60
Interest Coverage-6,05
Valorisation
P/E Ratio
-13,79
P/B Ratio3,46
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -12,21% | Revenue Growth (3Y) | -8,02% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | -20,87% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 407,21M | Net Income (TTM) | -91,21M |
| ROE | -22,23% | ROA | -6,55% |
| Gross Margin | 58,98% | Operating Margin | -22,52% |
| Net Margin | -22,40% | Free Cash Flow (TTM) | -343,18M |
| ROIC | -9,55% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,98 | Current Ratio | 1,60 |
| Interest Coverage | -6,05 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -13,79 | P/B Ratio | 3,46 |
| P/S Ratio | 3,09 | PEG Ratio | 0,31 |
| EV/EBITDA | N/A | Dividend Yield | 0,00% |
| Market Cap | 1,26B | Enterprise Value | 1,23B |
Income Statement
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | 407,21M | 463,84M | 481,36M | 243,72M | 1,04B |
| Net Income | -91,21M | -367,23M | -902,68M | -1,92B | -1,22B |
| EPS (Diluted) | -0,07 | -0,29 | -0,77 | -1,65 | -1,17 |
| Gross Profit | 240,15M | 304,30M | 278,38M | 136,89M | 797,41M |
| Operating Income | -91,69M | -579,85M | -912,15M | -1,83B | -1,09B |
Balance Sheet
Annual, most recent first
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Total Assets | 1,39B | 1,66B | 1,64B | 2,27B | 3,76B |
| Total Liabilities | 1,03B | 1,21B | 1,19B | 1,06B | 808,29M |
| Shareholders' Equity | 363,87M | 456,83M | 449,33M | 1,21B | 2,95B |
| Total Debt | 355,97M | 363,45M | 286,29M | 174,20M | 83,86M |
| Cash & Equivalents | 387,94M | 996,67M | 558,68M | 742,72M | 3,02B |
| Current Assets | 1,09B | 1,33B | 1,25B | 1,96B | 3,57B |
| Current Liabilities | 682,01M | 850,34M | 946,48M | 932,95M | 727,05M |